These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9518277)

  • 21. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.
    Dwyer R; Topp L; Maher L; Power R; Hellard M; Walsh N; Jauncey M; Conroy A; Lewis J; Aitken C
    Drug Alcohol Depend; 2009 Feb; 100(1-2):9-16. PubMed ID: 19013725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Young and recent-onset injecting drug users are at higher risk for HIV.
    Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA
    Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(13):329-32. PubMed ID: 19357632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexplained illness and death among injecting-drug users--Glasgow, Scotland; Dublin, Ireland; and England, April-June 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jun; 49(22):489-92. PubMed ID: 10881764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
    DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
    J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiated risk behaviour for HIV and hepatitis among injecting drug users (IDUs).
    Nordén L; Lidman C
    Scand J Infect Dis; 2005; 37(6-7):493-6. PubMed ID: 16012010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic].
    Krekulová L; Rehák V; Strunecký O; Nēmecek V
    Epidemiol Mikrobiol Imunol; 2009 Apr; 58(2):84-9. PubMed ID: 19526922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C treatment for injection drug users: a review of the available evidence.
    Hellard M; Sacks-Davis R; Gold J
    Clin Infect Dis; 2009 Aug; 49(4):561-73. PubMed ID: 19589081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
    Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
    Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal tetanus in a drug abuser with "protective" antitetanus antibodies.
    Abrahamian FM; Pollack CV; LoVecchio F; Nanda R; Carlson RW
    J Emerg Med; 2000 Feb; 18(2):189-93. PubMed ID: 10699520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexplained deaths among injection drug users: a case of probable Clostridium myonecrosis.
    Williamson N; Archibald C; Van Vliet JS
    CMAJ; 2001 Sep; 165(5):609-11. PubMed ID: 11563214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary syringe exchange among users of 23 California syringe exchange programs.
    Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
    Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand.
    Quan VM; Vongchak T; Jittiwutikarn J; Kawichai S; Srirak N; Wiboonnatakul K; Razak MH; Suriyanon V; Celentano DD
    Addiction; 2007 Mar; 102(3):441-6. PubMed ID: 17298652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
    Salmon AM; van Beek I; Amin J; Grulich A; Maher L
    Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical wound botulism in injecting drug addicts].
    Jensen T; Jacobsen D; von der Lippe E; Heier MS; Selseth B
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4363-5. PubMed ID: 9889608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetanus in injecting drug users.
    Beeching NJ; Crowcroft NS
    BMJ; 2005 Jan; 330(7485):208-9. PubMed ID: 15677636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.